We want to hear from you regarding Diabetes Management in Australia. If you're over 50 and living with diabetes, your insights on various treatment methods, including continuous glucose monitoring systems and insulin pumps, are valuable to us, whether you use these technologies or not.
By participating in our online survey, you'll contribute to a better understanding of the challenges and obstacles faced by adults aged 50+ years in adopting diabetes technology. Our goal is to use your valuable input to identify and highlight areas for future improvement in diabetes care. All survey responses will be entirely anonymous.
This is your chance to have your say about your diabetes and your treatment experiences. Survey will take around 30-40 minutes to complete (you can complete it in more than one sitting).
Survey ends 31st July 2024.
More information regarding our online survey can be found on the survey link below (or click here).
See below for our group's previous research publications on older adults and diabetes technologies
Kubilay E, Trawley S, Ward GM, Fourlanos S, Colman PG, McAuley SA. Real‐world lived experience of older adults with type 1 diabetes after an automated insulin delivery trial. Diabetic Medicine. 2023 Dec 10:e15264. Click here to read.
Trawley S, Kubilay E, Colman PG, Lee MH, O'Neal DN, Sundararajan V, Vogrin S, McAuley SA. What difference does sleep make? Continuous glucose monitoring metrics during fixed‐overnight time versus sleep periods among older adults with type 1 diabetes. Journal of Sleep Research. 2023 Dec 5:e14106. Click here to read.
Kwon HJ, Trawley S, Vogrin S, Mohammad Alipoor A, Colman PG, Fourlanos S, Grills CA, Lee MH, MacIsaac RJ, O'Neal DN, O'Regan NA. Driving-related glucose patterns among older adults with type 1 diabetes. Diabetes Technology and Therapeutics. 2024 Feb 5(ja). Click here to read.
Kubilay E, Trawley S, Ward GM, Fourlanos S, Grills CA, Lee MH, MacIsaac RJ, O'Neal DN, O'Regan NA, Sundararajan V, Vogrin S. Lived experience of older adults with type 1 diabetes using closed‐loop automated insulin delivery in a randomised trial. Diabetic Medicine. 2023 Apr;40(4):e15020. Click here to read.
Trawley S, Ward GM, Vogrin S, Colman PG, Fourlanos S, Grills CA, Lee MH, MacIsaac RJ, Alipoor AM, O'Neal DN, O'Regan NA. Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL study. The Lancet Healthy Longevity. 2022 Dec 1;3(12):e839-48. Click here to read.
McAuley SA, Trawley S, Vogrin S, Ward GM, Fourlanos S, Grills CA, Lee MH, Alipoor AM, O’Neal DN, O’Regan NA, Sundararajan V. Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial. Diabetes Care. 2022 Feb 1;45(2):381-90.